Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data.

ABSTRACT:

Background

Concerns about the role of chronically used medications in the clinical outcomes of the coronavirus disease 2019 (COVID-19) have remarkable potential for the breakdown of non-communicable diseases (NCDs) management by imposing ambivalence toward medication continuation. This study aimed to investigate the association of single or combinations of chronically used medications in NCDs with clinical outcomes of COVID-19.

Methods

This retrospective study was conducted on the intersection of two databases, the Iranian COVID-19 registry and Iran Health Insurance Organization. The primary outcome was death due to COVID-19 hospitalization, and secondary outcomes included length of hospital stay, Intensive Care Unit (ICU) admission, and ventilation therapy. The Anatomical T

SUBMITTER: Malekpour MR 

PROVIDER: S-EPMC9998941 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature